Condition Guide
Peptides for Immune Dysfunction
Thymosin Alpha-1 is the most widely studied immune peptide. It is approved in 30+ countries as adjunctive therapy in chronic viral hepatitis, sepsis, and cancer immunotherapy.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
How peptides help
Thymosin Alpha-1 stimulates dendritic cell maturation, promotes Th1 T-cell responses, and enhances NK cell cytotoxicity. Selank and Thymosin Beta-4 also have immune-related mechanisms.
Peptides researched for immune dysfunction
State of the evidence
Thymosin Alpha-1 has extensive international clinical data, though it is not FDA approved.
Frequently asked
Is Thymosin Alpha-1 FDA approved?
No, but it is approved in 30+ countries and has been studied extensively in chronic hepatitis, sepsis, and as an immunotherapy adjunct.
Related articles & guides
Peptide Therapy: What You Need to Know Before Starting
Guide · 14 min
Peptides for Women: Safety, Benefits, and What’s Different
Deep Dive · 14 min
RFK Jr. Announces 14 Peptides Moving Back to Category 1: What It Means
Regulatory · 7 min
Selank vs Semax: Russian Nootropic Peptides Compared
Comparison · 10 min
Thymosin Alpha-1 vs BPC-157: Immune Modulation vs Tissue Repair
Comparison · 8 min
BPC-157 vs Thymosin Alpha-1: Repair vs Immunity
Comparison · 8 min
Selank vs NAD+: Cognitive Enhancement Approaches
Comparison · 5 min